Dopaminergic and Cholinergic Interaction in Cataleptic Responses in Mice (Q42548133)

2 November 2017

title

Dopaminergic and cholinergic interaction in cataleptic responses in mice (English)

1 reference

2 November 2017

Dopaminergic and Cholinergic Interaction in Cataleptic Responses in Mice (English)

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(96)00478-9

12 November 2024

1 reference

I. Ushijima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

M. Kawano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

H. Kaneyuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

M. Suetsugi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

K. Usami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

H. Hirano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

Y. Mizuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

M. Yamada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9264077

12 November 2024

language of work or name

English

0 references

publication date

1 September 1997

1 reference

2 November 2017

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9264077

full work available at URL

12 November 2024

https://api.elsevier.com/content/article/PII:S0091305796004789?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(96)00478-9

https://api.elsevier.com/content/article/PII:S0091305796004789?httpAccept=text/plain

12 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(96)00478-9

Pharmacology, Biochemistry and Behavior

12 November 2024

published in

1 reference

2 November 2017

1 reference

2 November 2017

1 reference

2 November 2017

page(s)

103-108

1 reference

Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

[3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Behavioral correlations of dopamine receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Modification of apomorphine induced aggression by changing central cholinergic activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Evidence for a cholinergic role in haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Catalepsy induced by SCH 23390 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

The central effects of a novel dopamine agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Cocaine: evidence for NMDA- and opioid-mediated antinociception in the tail-flick test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900478-9

7 January 2021

Brain dopamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(96)00478-9

12 November 2024

Identifiers

1 reference

2 November 2017

1 reference